Cover storyCDMO trends 2026 show a structural consolidation wave — bigger deals, sharper specialization, and rising onshoring pressure reshaping manufacturing.
Telix reports US$477M in H1 2026 revenue, up 22%, as Illuccix and Gozellix scale and multiple regulatory reviews advance simultaneously.
B. Braun recalls one lot of Excel Lactated Ringers 1000mL over cellulose and polystyrene particulate contamination distributed across the US and Canada.
FDA grants accelerated approval to Genglycos for GSDIa, the first gene therapy for the condition, with confirmatory trial obligations ahead.
Regeneron's Pasatru gains FDA approval for FOP, with home infusion support raising GMP, cold-chain, and packaging compliance questions for ultra-rare biologics.
Latest edition
Interview20260622153015.png&w=1920&q=75&dpl=dpl_E7qxWMsBZVC6pHYR7miAbhf2ivM3)
Interview
Interview
Podcast
Sep 28
Nov 18
Feb 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.
Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
20260804110923.webp&w=1920&q=75&dpl=dpl_E7qxWMsBZVC6pHYR7miAbhf2ivM3)
